Neurological


Last updated:
Total hit(s): 17
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
This research had focused on evaluating the presence of symptoms of Anxiety Disorder in adolescents with hearing loss during the COVID-19 pandemic. Among the deaf participants,18 were pre-lingually deaf and 5 were post-lingually deaf. Of the hard of hearing participants, 23 used hearing aids
33618708
(BMC Psychiatry)
PMID
33618708
Date of Publishing: 2021 Feb 22
Title Symptoms of anxiety disorders in Iranian adolescents with hearing loss during the COVID-19 pandemic
Author(s) name Ariapooran S, Khezeli M.
Journal BMC Psychiatry
Impact factor
2.86
Citation count: 1


A cross sectional study including 105 patients with documented clinical recovery and virological clearance to evaluate the prevalence of anxiety or/and depression. 1. The patients underwent medical examination one to three months after virological clearance.
32841387
(J Med Virol)
PMID
32841387
Date of Publishing: 2021 Feb
Title Anxiety and depression symptoms after virological clearance of COVID19: a crosssectional study in Milan, Italy
Author(s) nameTomasoni D, Bai F et al.
Journal J Med Virol
Impact factor
2.07
Citation count: 2


A case study in Mexico, of a SARS-CoV-2 positive patient with an acute episode of pychosis as the only symptom. Lab results revealed Hypokalemia K 3.3, elevation of hepatic enzymes -aspartate aminotransferase 53U/L, alanine aminotransferase 69U/L, indirect hyperbilirubinemia and elevated ferritin levels (595ng/mL).
33472577
(Int J Emerg Med)
PMID
33472577
Date of Publishing: 2021 Jan 20
Title Hiccups and psychosis: two atypical presentations of COVID-19
Author(s) name Alvarez-Cisneros T, Lara-Reyes A, Sansón-Tinoco S.
Journal Int J Emerg Med
Citation count 1


A study among clinical healthcare workers to determine rates of anxiety and depression and the factors associated with their prevalence. The questionnaire included Perceived Stress Scale-10 (PSS-10), Generalized Anxiety Disorder 7-Item Scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9). Factors associated with anxiety and depression symptoms were estimated by logistic regression analysis.The database was constructed by using EpiDate3.1 and analyzed by SPSS 25.0.
32961409
(J Affect Disord)
PMID
32961409
Date of Publishing: 2021 Jan 1
Title Anxiety and depression symptoms of medical staff under COVID-19 epidemic in China
Author(s) nameLiu Y, Chen H et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 4


103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus. Depression and anxiety are frequent symptoms in patients with SARS-CoV2 infection needing careful medical evaluation and follow-up. Moreover, counteracting these neuropsychological symptoms can improve the reaction to the infection and can need of specific treatments in order to improve the possibility of rehabilitation and recovery.
32987349
(J Affect Disord)
PMID
32987349
Date of Publishing: 2021 Jan 1
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 1


103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus. Depression and anxiety are frequent symptoms in patients with SARS-CoV2 infection needing careful medical evaluation and follow-up. Moreover, counteracting these neuropsychological symptoms can improve the reaction to the infection and can need of specific treatments in order to improve the possibility of rehabilitation and recovery.
32987349
(J Affect Disord)
PMID
32987349
Date of Publishing: 2021 Jan 1
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 1


2701 volunteers were surveyed to assess perceived stress, sleep quality, insomnia, depression symptoms, and anxiety, using standard questionnaires.
33102641
(Neurobiol Stress)
PMID
33102641
Date of Publishing: 2020 Nov
Title Gender-related time course of sleep disturbances and psychological symptoms during the COVID-19 lockdown: a longitudinal study on the Italian population
Author(s) nameSalfi F, Lauriola M et al.
Journal Neurobiol Stress
Citation count 1


2701 volunteers were surveyed to assess perceived stress, sleep quality, insomnia, depression symptoms, and anxiety, using standard questionnaires. The Pittsburgh Sleep Quality Index (PSQI), the Insomnia Severity Index (ISI), the Beck Depression Inventory-second edition (BDI-II), the 10-item Perceived Stress Scale (PSS-10), and the state-anxiety subscale of the State-Trait Anxiety Inventory (STAI-X1) were the questionnaires used in this study
33102641
(Neurobiol Stress)
PMID
33102641
Date of Publishing: 2020 Nov
Title Gender-related time course of sleep disturbances and psychological symptoms during the COVID-19 lockdown: a longitudinal study on the Italian population
Author(s) nameSalfi F, Lauriola M et al.
Journal Neurobiol Stress
Citation count 1


Most common neurologic symptom was Headache (15%) and least common was Insomnia (0.8%) out of 68 symptomatic cases.
33154280
(Niger Postgrad Med J)
PMID
33154280
Date of Publishing: 2020 Oct-Dec
Title Clinical characteristics, predictors of symptomatic coronavirus disease 2019 and duration of hospitalisation in a cohort of 632 Patients in Lagos State, Nigeria
Author(s) nameErinoso OA, Wright KO et al.
Journal Niger Postgrad Med J
Citation count 1


51417 adult volunteers were surveyed to examine the extent of effects of sociodemographic, psychosocial, and health-related factors on mental health during the COVID-19 pandemic Depressive symptoms were measured on 7 occasions from March 21 to April 2, 2020, using the 9-item Patient Health Questionnaire (PHQ-9). Group-based depressive symptom trajectories were derived using latent growth mixture modeling
33104209
(JAMA Netw Open)
PMID
33104209
Date of Publishing: 2020 Oct 1
Title Levels of Severity of Depressive Symptoms Among At-Risk Groups in the UK During the COVID-19 Pandemic
Author(s) nameIob E, Frank P et al.
Journal JAMA Netw Open
Impact factor
5.032
Citation count: 4


51417 adult volunteers were surveyed to examine the extent of effects of sociodemographic, psychosocial, and health-related factors on mental health during the COVID-19 pandemic Depressive symptoms were measured on 7 occasions from March 21 to April 2, 2020, using the 9-item Patient Health Questionnaire (PHQ-9). Group-based depressive symptom trajectories were derived using latent growth mixture modeling
33104209
(JAMA Netw Open)
PMID
33104209
Date of Publishing: 2020 Oct 1
Title Levels of Severity of Depressive Symptoms Among At-Risk Groups in the UK During the COVID-19 Pandemic
Author(s) nameIob E, Frank P et al.
Journal JAMA Netw Open
Impact factor
5.032
Citation count: 4


A case study was carried out on a patient from Wuhan, who presented with neurological symptoms. Some patients may present with neurologic signs, such as headache, nausea, and vomiting or loss of smell and taste, encephalitis.
32293714
(J Med Virol)
PMID
32293714
Date of Publishing: 2020 Oct
Title Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019
Author(s) nameYin R, Feng W et al.
Journal J Med Virol
Impact factor
2.07
Citation count: 38


103 COVID-19 patients were screened for 13 subjective neurological symptoms and 91% of them were found to be suffering from atleast one of them. The possibly intrinsic neurotropic properties of SARS-CoV2 may justify the very high frequency of sNS. Further studies targeted at investigating the consequences of SARS-CoV2 infection on the CNS should be planned.
32416289
(Brain Behav Immun)
PMID
32416289
Date of Publishing: 2020 Aug
Title Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal Brain Behav Immun
Impact factor
6.13
Citation count: 29


A study to evaluate the relationship between physical and psychological symptoms of COVID-19 among healthcare workers. Depression, anxiety and stress were assessed using Depression Anxiety Stress Scales (DASS-21).The psychological distress of the outbreak was assessed using the Impact of Events Scale-Revised (IES-R).
32330593
(Brain Behav Immun)
PMID
32330593
Date of Publishing: 2020 Aug
Title A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID19 outbreak
Author(s) nameChew NWS, Lee GKH et al.
Journal Brain Behav Immun
Impact factor
6.13
Citation count: 143


103 COVID-19 patients were screened for 13 subjective neurological symptoms and 91% of them were found to be suffering from atleast one of them. The possibly intrinsic neurotropic properties of SARS-CoV2 may justify the very high frequency of sNS. Further studies targeted at investigating the consequences of SARS-CoV2 infection on the CNS should be planned.
32416289
(Brain Behav Immun)
PMID
32416289
Date of Publishing: 2020 Aug
Title Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal Brain Behav Immun
Impact factor
6.13
Citation count: 29


A comparative study of immediate stress and psychological impact experienced by people with and without psychiatric illnesses during the peak of SARS-CoV-2 infection confirms the severity of negative psychological impact on psychiatric patients. The following questionnaires were used: 1. Impact of Event Scale-Revised (IES-R) to measures posttraumatic stress disorder (PTSD) symptoms in survivorship during COVID-19 pandemic. ( scores 18-23- PTSD like symptoms, > 24- diagnosis of PTSD) 2. Mental health status was measured using the Depression, Anxiety and Stress Scale (DASS-21). 3.The sleep quality of respondents was measured using the Insomnia Severity Index (ISI). (Scores of 8-14 corresponds to subthreshold insomnia,15- 21 corresponds to moderately severe clinical insomnia and scores of 22-28 corresponds to severe clinical insomnia.)
32353518
(Brain Behav Immun)
PMID
32353518
Date of Publishing: 2020 Jul
Title Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry
Author(s) nameHao F, Tan W et al.
Journal Brain Behav Immun
Impact factor
6.13
Citation count: 108


A survvey of 217 hospitalized patients to predict a possible delayed post-viral sequelae of COVID-19 and possible mechanisms behind the development of these neuropsychiatric symptoms. Anti-CoV antibodies have been identified in cerebrospinal fluid (CSF) of individuals with Parkinsons disease. Neural and immune cells can serve as reservoirs of latent CoV and thus could contribute to delayed neurodegenerative processes . Can be speculated that SARS CoV- 2 precipitates affect the gut microbial composition that could lead to pathogenesis of neuropsychiatric symptoms via the gut-brain axis.
32298803
(Brain Behav Immun)
PMID
32298803
Date of Publishing: 2020 Jul
Title Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
Author(s) name Troyer EA, Kohn JN, Hong S.
Journal Brain Behav Immun
Impact factor
6.13
Citation count: 119